In the last 12 months, insiders at Aprea Therapeutics, Inc. ($APRE) filed 80 transactions with the SEC: 37 open-market purchases totaling $358,923 and 1 sales totaling $29,583. Net insider sentiment: net buying.
Aprea Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Duey Marc (Director) — 9 transactions totaling $186,773
- Seizinger Bernd R. (Director) — 8 transactions totaling $76,809
- HENNEMAN JOHN B III (Director) — 7 transactions totaling $50,009
- Gilad Oren (President/CEO) — 14 transactions totaling $40,774
- Hamill John P. (SrVP/CFO/Prin Fin & Acct Ofcr) — 17 transactions totaling $19,559
View all SEC Filings for Aprea Therapeutics, Inc. (APRE).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | P | Common Warrant | 30978 | $0.00 | 30,978.0000 | 6,538,722 | 9999.99% | 0.47% |
| March 31, 2026 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | P | Pre-Funded Warrant | 30978 | $0.81 | 30,978.0000 | 6,538,722 | 9999.99% | 0.47% |
| March 31, 2026 | Peters Richard | Director | P | Common Warrant | 123915 | $0.00 | 123,915.0000 | 6,538,722 | 9999.99% | 1.90% |
| March 31, 2026 | Peters Richard | Director | P | Pre-Funded Warrant | 123915 | $0.81 | 123,915.0000 | 6,538,722 | 9999.99% | 1.90% |
| March 12, 2026 | Gilad Oren | President/CEO | A | Common Stock | 20175 | $0.00 | 395,695.0000 | 6,372,938 | 5.37% | 0.32% |
| March 12, 2026 | Gilad Oren | President/CEO | A | Stock Options (Right to Buy) | 80700 | $0.00 | 80,700.0000 | 6,372,938 | 9999.99% | 1.27% |
| March 12, 2026 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | A | Common Stock | 10095 | $0.00 | 43,528.0000 | 6,372,938 | 30.19% | 0.16% |
| March 12, 2026 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | A | Stock Options (Right to Buy) | 40380 | $0.00 | 40,380.0000 | 6,372,938 | 9999.99% | 0.63% |
| Jan. 30, 2026 | Gilad Oren | President/CEO | P | Common Warrant | 28100 | $0.00 | 28,100.0000 | 6,372,938 | 9999.99% | 0.44% |
| Jan. 30, 2026 | Gilad Oren | President/CEO | P | Common Stock | 28100 | $0.89 | 375,520.0000 | 6,372,938 | 8.09% | 0.44% |
| Jan. 30, 2026 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | P | Common Warrant | 5700 | $0.00 | 5,700.0000 | 6,372,938 | 9999.99% | 0.09% |
| Jan. 30, 2026 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | P | Common Stock | 5700 | $0.89 | 33,433.0000 | 6,372,938 | 20.55% | 0.09% |
| Dec. 10, 2025 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | P | Common Warrant | 5000 | $0.00 | 5,000.0000 | 6,372,938 | 9999.99% | 0.08% |
| Dec. 10, 2025 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | P | Common Stock | 5000 | $1.17 | 27,733.0000 | 6,372,938 | 21.99% | 0.08% |
| Dec. 10, 2025 | Duey Marc | Director | P | Common Warrant | 21459 | $0.00 | 21,459.0000 | 6,372,938 | 9999.99% | 0.34% |
| Dec. 10, 2025 | Duey Marc | Director | P | Common Stock | 21459 | $1.17 | 256,757.0000 | 6,372,938 | 9.12% | 0.34% |
| Dec. 10, 2025 | Gilad Oren | President/CEO | P | Common Warrants | 21459 | $0.00 | 21,459.0000 | 6,372,938 | 9999.99% | 0.34% |
| Dec. 10, 2025 | Gilad Oren | President/CEO | P | Pre-Funded Warrant | 21459 | $1.17 | 21,459.0000 | 6,372,938 | 9999.99% | 0.34% |
| June 5, 2025 | HENNEMAN JOHN B III | Director | A | Common Stock | 1045 | $0.00 | 10,229.0000 | 5,993,866 | 11.38% | 0.02% |
| June 5, 2025 | Seizinger Bernd R. | Director | A | Common Stock | 1045 | $0.00 | 45,775.0000 | 5,993,866 | 2.34% | 0.02% |
| June 5, 2025 | Seizinger Bernd R. | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 5,993,866 | 9999.99% | 0.07% |
| June 5, 2025 | Peters Richard | Director | A | Common Stock | 1045 | $0.00 | 3,119.0000 | 5,993,866 | 50.39% | 0.02% |
| June 5, 2025 | Peters Richard | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 5,993,866 | 9999.99% | 0.07% |
| June 5, 2025 | Pamukcu Rifat | Director | A | Common Stock | 1045 | $0.00 | 19,554.0000 | 5,993,866 | 5.65% | 0.02% |
| June 5, 2025 | Pamukcu Rifat | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 5,993,866 | 9999.99% | 0.07% |
| June 5, 2025 | HENNEMAN JOHN B III | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 5,993,866 | 9999.99% | 0.07% |
| June 5, 2025 | Gruia Gabriela | Director | A | Common Stock | 1045 | $0.00 | 1,045.0000 | 5,993,866 | 9999.99% | 0.02% |
| June 5, 2025 | Gruia Gabriela | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 5,993,866 | 9999.99% | 0.07% |
| June 5, 2025 | Grissinger Michael | Director | A | Common Stock | 1045 | $0.00 | 2,889.0000 | 5,993,866 | 56.67% | 0.02% |
| June 5, 2025 | Grissinger Michael | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 5,993,866 | 9999.99% | 0.07% |
| June 5, 2025 | Duey Marc | Director | A | Common Stock | 1045 | $0.00 | 235,298.0000 | 5,993,866 | 0.45% | 0.02% |
| June 5, 2025 | Duey Marc | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 5,993,866 | 9999.99% | 0.07% |
| June 5, 2025 | BIZZARI JEAN-PIERRE | Director | A | Common Stock | 1045 | $0.00 | 1,045.0000 | 5,993,866 | 9999.99% | 0.02% |
| June 5, 2025 | BIZZARI JEAN-PIERRE | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 5,993,866 | 9999.99% | 0.07% |
| April 3, 2025 | Gilad Oren | President/CEO | P | Common Stock | 2497 | $1.80 | 347,420.0000 | 5,993,866 | 0.72% | 0.04% |
| April 3, 2025 | Gilad Oren | President/CEO | P | Common Stock | 3003 | $1.87 | 344,923.0000 | 5,993,866 | 0.88% | 0.05% |
| March 27, 2025 | Gilad Oren | President/CEO | A | Common Stock | 6725 | $0.00 | 341,920.0000 | 5,509,921 | 2.01% | 0.12% |
| March 27, 2025 | Gilad Oren | President/CEO | A | Stock Options (Right to Buy) | 26900 | $0.00 | 26,900.0000 | 5,509,921 | 9999.99% | 0.49% |
| March 27, 2025 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | A | Common Stock | 3365 | $0.00 | 22,733.0000 | 5,509,921 | 17.37% | 0.06% |
| March 27, 2025 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | A | Stock Options (Right to Buy) | 13460 | $0.00 | 13,460.0000 | 5,509,921 | 9999.99% | 0.24% |
| Oct. 18, 2024 | Duey Marc | Director | S | Common Stock | 6462 | $4.58 | 234,253.0000 | 5,939,755 | 2.68% | 0.11% |
| Oct. 23, 2024 | Gilad Oren | President/CEO | P | Common Stock | 500 | $3.92 | 335,195.0000 | 5,939,755 | 0.15% | 0.01% |
| Oct. 16, 2024 | Duey Marc | Director | P | Common Stock | 30000 | $4.39 | 240,715.0000 | 5,939,755 | 14.24% | 0.51% |
| Oct. 11, 2024 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | P | Common Stock | 50 | $2.46 | 19,368.0000 | 5,939,755 | 0.26% | 0.00% |
| Oct. 14, 2024 | Duey Marc | Director | P | Common Stock | 190 | $2.58 | 210,715.0000 | 5,939,755 | 0.09% | 0.00% |
| Oct. 15, 2024 | Gilad Oren | President/CEO | P | Common Stock | 250 | $2.90 | 334,695.0000 | 5,939,755 | 0.07% | 0.00% |
| Oct. 10, 2024 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | P | Common Stock | 450 | $2.61 | 19,318.0000 | 5,939,755 | 2.38% | 0.01% |
| Oct. 14, 2024 | Gilad Oren | President/CEO | P | Common Stock | 1000 | $2.59 | 334,445.0000 | 5,939,755 | 0.30% | 0.02% |
| Oct. 11, 2024 | Seizinger Bernd R. | Director | P | Common Stock | 10000 | $2.68 | 44,730.0000 | 5,939,755 | 28.79% | 0.17% |
| Oct. 10, 2024 | Gilad Oren | President/CEO | P | Common Stock | 150 | $2.54 | 333,445.0000 | 5,939,755 | 0.05% | 0.00% |
| June 20, 2024 | Grissinger Michael | Director | A | Common Stock | 1045 | $0.00 | 1,844.0000 | 4,198,326 | 130.79% | 0.02% |
| June 20, 2024 | Seizinger Bernd R. | Director | A | Common Stock | 1045 | $0.00 | 34,730.0000 | 4,198,326 | 3.10% | 0.02% |
| June 20, 2024 | Seizinger Bernd R. | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 4,198,326 | 9999.99% | 0.10% |
| June 20, 2024 | Pamukcu Rifat | Director | A | Common Stock | 1045 | $0.00 | 18,509.0000 | 4,198,326 | 5.98% | 0.02% |
| June 20, 2024 | Pamukcu Rifat | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 4,198,326 | 9999.99% | 0.10% |
| June 20, 2024 | Peters Richard | Director | A | Common Stock | 1045 | $0.00 | 2,074.0000 | 4,198,326 | 101.55% | 0.02% |
| June 20, 2024 | Peters Richard | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 4,198,326 | 9999.99% | 0.10% |
| June 20, 2024 | HENNEMAN JOHN B III | Director | A | Common Stock | 1045 | $0.00 | 9,184.0000 | 4,198,326 | 12.84% | 0.02% |
| June 20, 2024 | HENNEMAN JOHN B III | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 4,198,326 | 9999.99% | 0.10% |
| June 20, 2024 | Grissinger Michael | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 4,198,326 | 9999.99% | 0.10% |
| June 20, 2024 | Duey Marc | Director | A | Common Stock | 1045 | $0.00 | 210,525.0000 | 4,198,326 | 0.50% | 0.02% |
| June 20, 2024 | Duey Marc | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 4,198,326 | 9999.99% | 0.10% |
| May 1, 2024 | Mirza Nadeem Q. | Chief Medical Officer | A | Stock Options (Right to Purchase) | 26920 | $0.00 | 26,920.0000 | 4,198,326 | 9999.99% | 0.64% |
| May 1, 2024 | Mirza Nadeem Q. | Chief Medical Officer | A | Common Stock | 6730 | $0.00 | 6,730.0000 | 4,198,326 | 9999.99% | 0.16% |
| March 28, 2024 | Gilad Oren | President, CEO | A | Stock Options (Right to Buy) | 26900 | $0.00 | 26,900.0000 | 3,617,607 | 9999.99% | 0.74% |
| March 28, 2024 | Gilad Oren | President, CEO | A | Common Stock | 6725 | $0.00 | 333,295.0000 | 3,617,607 | 2.06% | 0.19% |
| March 28, 2024 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | A | Stock Options (Right to Buy) | 13460 | $0.00 | 13,460.0000 | 3,617,607 | 9999.99% | 0.37% |
| March 28, 2024 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | A | Common Stock | 3365 | $0.00 | 18,868.0000 | 3,617,607 | 21.71% | 0.09% |
| March 13, 2024 | Seizinger Bernd R. | Director | P | Tranche B Warrant | 3430 | $0.00 | 3,430.0000 | 3,617,607 | 9999.99% | 0.09% |
| March 13, 2024 | Seizinger Bernd R. | Director | P | Tranche A Warrant | 3430 | $0.00 | 3,430.0000 | 3,617,607 | 9999.99% | 0.09% |
| March 13, 2024 | Seizinger Bernd R. | Director | P | Common Stock | 6860 | $7.29 | 33,685.0000 | 3,617,607 | 25.57% | 0.19% |
| March 13, 2024 | HENNEMAN JOHN B III | Director | P | Tranche B Warrant | 3430 | $0.00 | 3,430.0000 | 3,617,607 | 9999.99% | 0.09% |
| March 13, 2024 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | P | Tranche A Warrant | 505 | $0.00 | 505.0000 | 3,617,607 | 9999.99% | 0.01% |
| March 13, 2024 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | P | Common Stock | 1010 | $7.29 | 15,503.0000 | 3,617,607 | 6.97% | 0.03% |
| March 13, 2024 | Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | P | Tranche B Warrant | 505 | $0.00 | 505.0000 | 3,617,607 | 9999.99% | 0.01% |
| March 13, 2024 | Gilad Oren | President, CEO | P | Common Stock | 2000 | $7.29 | 324,770.0000 | 3,617,607 | 0.62% | 0.06% |
| March 13, 2024 | Gilad Oren | President, CEO | P | Tranche A Warrant | 1000 | $0.00 | 1,000.0000 | 3,617,607 | 9999.99% | 0.03% |
| March 13, 2024 | Gilad Oren | President, CEO | P | Tranche B Warrant | 1000 | $0.00 | 1,000.0000 | 3,617,607 | 9999.99% | 0.03% |
| March 13, 2024 | HENNEMAN JOHN B III | Director | P | Tranche A Warrant | 3430 | $0.00 | 3,430.0000 | 3,617,607 | 9999.99% | 0.09% |
| March 13, 2024 | HENNEMAN JOHN B III | Director | P | Common Stock | 6860 | $7.29 | 8,139.0000 | 3,617,607 | 536.36% | 0.19% |